110 related articles for article (PubMed ID: 34987161)
1. Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.
Jain A; Nayak L; Kulkarni UP; Mehra N; Yanamandra U; Kayal S; Damodar S; John JM; Mehta P; Singh S; Munot P; Selvarajan S; Radhakrishnan V; Lad D; Kapoor R; Dubashi B; Bharath RS; Jain H; Jayachandran PK; Lakshmanan J; Mani T; Thorat J; Das S; Karunamurthy O; George B; Sengar M; Malhotra P
Blood Cancer J; 2022 Jan; 12(1):2. PubMed ID: 34987161
[No Abstract] [Full Text] [Related]
2. Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time.
Cattaneo C; Pagani C; Cancelli V; Imberti L; Roccaro AM; Notarangelo LD; Rossi G
Leukemia; 2021 Feb; 35(2):632-634. PubMed ID: 32770087
[No Abstract] [Full Text] [Related]
3. Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.
Garnett C; Foldes D; Bailey C; Nesr G; Hui T; Hinton R; Gurung K; Phillips J; Saleem Z; Koshy R; Aduwa E; Colis M; Bimolah R; Katsomitrou V; Arami S; Kagdi H
Leuk Lymphoma; 2021 Feb; 62(2):469-472. PubMed ID: 33167718
[No Abstract] [Full Text] [Related]
4. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
Wood WA; Neuberg DS; Thompson JC; Tallman MS; Sekeres MA; Sehn LH; Anderson KC; Goldberg AD; Pennell NA; Niemeyer CM; Tucker E; Hewitt K; Plovnick RM; Hicks LK
Blood Adv; 2020 Dec; 4(23):5966-5975. PubMed ID: 33278301
[TBL] [Abstract][Full Text] [Related]
5. ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.
Oncologist; 2021 Feb; 26 Suppl 1(Suppl 1):S17-S18. PubMed ID: 33368829
[TBL] [Abstract][Full Text] [Related]
6. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Russell B; Moss CL; Shah V; Ko TK; Palmer K; Sylva R; George G; Monroy-Iglesias MJ; Patten P; Ceesay MM; Benjamin R; Potter V; Pagliuca A; Papa S; Irshad S; Ross P; Spicer J; Kordasti S; Crawley D; Wylie H; Cahill F; Haire A; Zaki K; Sita-Lumsden A; Josephs D; Enting D; Swampillai A; Sawyer E; D'Souza A; Gomberg S; Harrison C; Fields P; Wrench D; Rigg A; Sullivan R; Kulasekararaj A; ; Dolly S; Van Hemelrijck M
Br J Cancer; 2021 Sep; 125(7):939-947. PubMed ID: 34400804
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.
Arcani R; Colle J; Cauchois R; Koubi M; Jarrot PA; Jean R; Boyer A; Lachamp J; Tichadou A; Couderc AL; Farnault L; Costello R; Venton G; Kaplanski G
Ann Hematol; 2021 Nov; 100(11):2799-2803. PubMed ID: 34518918
[TBL] [Abstract][Full Text] [Related]
8. Impact of Covid19 on a tertiary care pediatric oncology and stem cell transplant unit in Riyadh, Saudi Arabia.
Ahmad N; Essa MF; Sudairy R
Pediatr Blood Cancer; 2020 Sep; 67(9):e28560. PubMed ID: 32654375
[No Abstract] [Full Text] [Related]
9. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
Gupta A; Desai N; Sanjeev ; Chauhan P; Nityanand S; Hashim Z; Gupta M
Ann Hematol; 2022 Jan; 101(1):69-79. PubMed ID: 34559278
[TBL] [Abstract][Full Text] [Related]
10. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
Wang Q; Berger NA; Xu R
Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cattaneo C; Daffini R; Pagani C; Salvetti M; Mancini V; Borlenghi E; D'Adda M; Oberti M; Paini A; De Ciuceis C; Barbullushi K; Cancelli V; Belotti A; Re A; Motta M; Peli A; Bianchetti N; Anastasia A; Dalceggio D; Roccaro AM; Tucci A; Cairoli R; Muiesan ML; Rossi G
Cancer; 2020 Dec; 126(23):5069-5076. PubMed ID: 32910456
[TBL] [Abstract][Full Text] [Related]
12. The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.
Condom M; Mussetti A; Maluquer C; Parody R; González-Barca E; Arnan M; Albasanz-Puig A; Pomares H; Salas MQ; Carro I; Peña M; Clapes V; Baca Cano C; Oliveira Ramos AC; Sanz-Linares G; Moreno-González G; Mercadal S; Boqué C; Gudiol C; Domingo-Domènech E; Sureda A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1358. PubMed ID: 33656801
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.
Vijenthira A; Gong IY; Fox TA; Booth S; Cook G; Fattizzo B; Martín-Moro F; Razanamahery J; Riches JC; Zwicker J; Patell R; Vekemans MC; Scarfò L; Chatzikonstantinou T; Yildiz H; Lattenist R; Mantzaris I; Wood WA; Hicks LK
Blood; 2020 Dec; 136(25):2881-2892. PubMed ID: 33113551
[TBL] [Abstract][Full Text] [Related]
14. High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.
Niu A; Ning B; Socola F; Safah H; Reynolds T; Ibrahim M; Safa F; Alfonso T; Luk A; Mushatt DM; Hu T; Saba NS
Leuk Res; 2021 Jul; 106():106582. PubMed ID: 33933714
[No Abstract] [Full Text] [Related]
15. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) - National Neonatology Forum (NNF) India COVID-19 Registry.
More K; Chawla D; Murki S; Tandur B; Deorari AK; Kumar P;
Indian Pediatr; 2021 Jun; 58(6):525-531. PubMed ID: 33742609
[TBL] [Abstract][Full Text] [Related]
17. Delta threatens rural regions that dodged earlier COVID waves.
Mallapaty S
Nature; 2021 Aug; 596(7872):325-326. PubMed ID: 34354278
[No Abstract] [Full Text] [Related]
18. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
Borah P; Mirgh S; Sharma SK; Bansal S; Dixit A; Dolai TK; Lunkad S; Gupta N; Singh G; Jain A; Bansal D; Choudhary D; Khandelwal V; Doval D; Kumar M; Bhargava R; Chakrabarti A; Kalashetty M; Rauthan A; Kazi B; Mandal PK; Jeyaraman P; Naithani R;
Blood Cells Mol Dis; 2021 Mar; 87():102525. PubMed ID: 33338697
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey.
Ljungman P; de la Camara R; Mikulska M; Tridello G; Aguado B; Zahrani MA; Apperley J; Berceanu A; Bofarull RM; Calbacho M; Ciceri F; Lopez-Corral L; Crippa C; Fox ML; Grassi A; Jimenez MJ; Demir SK; Kwon M; Llamas CV; Lorenzo JLL; Mielke S; Orchard K; Porras RP; Vallisa D; Xhaard A; Knelange NS; Cedillo A; Kröger N; Piñana JL; Styczynski J
Leukemia; 2021 Oct; 35(10):2885-2894. PubMed ID: 34079042
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 variant from India to Marseille: The still active role of ports in the introduction of epidemics.
La Scola B; Lavrard P; Fournier PE; Colson P; Lacoste A; Raoult D
Travel Med Infect Dis; 2021; 42():102085. PubMed ID: 34029710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
